Overview

The Expert Exchange is an engaging and dynamic format that encourages audience involvement and provides a flexible framework within which to incorporate rapidly-emerging data. This interactive symposium will feature several relevant case-based discussions with audience voting on ARS keypads. Case topics have been cultivated from top issues by expert faculty and will include an examination of the evolving role of checkpoint inhibition across various stages of the bladder cancer disease continuum, with particular emphasis on novel approaches in advanced disease. Expert faculty will also explore the latest evidence for managing disease progression, sequencing and/or combining ICI therapy with FGFR inhibitors and ADCs, the appropriate duration of treatment, and proactive strategies for anticipating and managing immune-related adverse events (irAEs) that may occur in bladder cancer patients taking checkpoint inhibitors.

View All Speakers

Speakers

Neal Shore, MD, FACS


Atlantic Urology Clinics Myrtle Beach, South Carolina
View Full Bio

Ashish Kamat, MD, MBBS, FACS


University of Texas, MD Anderson Cancer Center Houston, Texas
View Full Bio

Robert Dreicer, MD, MS, MACP, FASCO


University of Virginia School of Medicine Charlottesville, Virginia
View Full Bio

Accreditation

CME

In support of improving patient care, Creative Educational Concepts is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CEC designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Other

Creative Educational Concepts, Inc. certifies this activity for 1.50 hours of participation.

Acknowledgement

This educational activity is supported through an independent educational grant from AstraZeneca.